Health in Democratic Republic of Congo 1,591 indicators covering health for Democratic Republic of Congo. IndicatorLatest Year10-yr change Rank Estimate of current cigarette smoking prevalence 7.5% 2030 down 8.5% 115th Estimate of current cigarette smoking prevalence (%) 8.1% 2030 down 8.0% 111th Leprosy - Number of new leprosy cases among children 243 2025 down 50.0% 4th New leprosy child case detection rate (less than 15 years of age) per 4.69 2025 down 65.9% 25th Constant stillbirth rate 25.86 2030 unchanged 10th ENAP target met stillbirth rate 12 2030 down 48.2% 1st Stillbirth rate high-income country 2.8 2030 down 85.1% 1st Stillbirths remain constant projection 131,556 2030 up 10.9% 5th Stillbirth maintained projection 114,621 2030 down 1.5% 4th Stillbirth ENAP 2030 target met projection 60,180 2030 down 43.2% 4th Stillbirth high-income country average rate matched projection 13,912 2030 down 83.8% 5th Stillbirth rate current trends 22.61 2030 down 10.9% 10th Life satisfaction vs. life expectancy 61.9 years 2023 up 7.1% 224th Number of female leprosy new cases 1,037 2025 down 45.0% 7th Low birth weight prevalence 10.2% 2020 down 9.7% 78th Tuberculosis patients who tested positive for HIV 13,373 patients 2021 up 170.6% 9th Number of children aged 6-59 months with anaemia 10,061 2019 up 22.6% 5th Prevalence of anaemia in children aged 6-59 months 64.9% 2019 down 7.2% 18th Mean hemoglobin level of children aged 6-59 months 103 2019 up 2.0% 177th Estimated number of MDR/RR-TB incident cases 6,900 2024 down 21.6% 12th Neonatal mortality rate - Remains constant 23.62 2030 unchanged 26th Neonatal mortality rate - Current trends maintained 23.37 2030 down 0.9% 22nd Neonatal mortality rate - High-income country average rate matched 2.8 2030 down 83.1% 1st Neonatal mortality rate - SDG target met 12 2030 down 43.1% 1st Under 5 mortality rate - Remains constant 89.68 2030 unchanged 9th Under 5 mortality rate - Current trends maintained 87.3 2030 down 2.2% 4th Under 5 mortality rate - High-income country average rate matched 5.09 2030 down 90.6% 1st Under 5 mortality rate - SDG target met 25 2030 down 65.0% 1st Mortality rate age 10-19 - Remains constant 23.35 2030 up 6.1% 3rd Mortality rate age 10-19 - Current trends maintained 21.15 2030 down 2.2% 2nd Mortality rate age 10-19 - High-income country average rate matched 5.66 2030 down 63.7% 2nd Neonatal deaths - Remains constant 116,939 2030 up 8.7% 4th Neonatal deaths - Current trends maintained 115,709 2030 up 7.7% 4th Neonatal deaths - SDG target met 59,421 2030 down 38.2% 4th Under-five deaths - Remains constant 431,592 2030 up 9.6% 3rd Under-five deaths - Current trends maintained 420,301 2030 up 7.2% 3rd Under-five deaths - SDG target met 121,228 2030 down 61.2% 4th Deaths age 10 to 19 - Remains constant 66,734 2030 up 19.2% 3rd Deaths age 10 to 19 - Current trends maintained 64,755 2030 up 16.3% 3rd Number of deaths attributed to non-communicable diseases, by type of 38,857 2019 up 46.8% 35th Hepatitis B surface antigen (HBsAg) prevalence 1.4% 2024 down 12.5% 19th Mortality caused by road traffic injury 34.9 per 100,000 population 2019 down 3.9% 10th Mortality caused by road traffic injury, female 24.4 per 100,000 female population 2019 down 8.3% 3rd Mortality caused by road traffic injury, male 45.4 per 100,000 male population 2019 down 1.5% 21st Number of new G2D leprosy cases 311 2025 down 46.1% 5th Leprosy - New leprosy cases with G2D rate per 1 000 000 population 2.76 2025 down 63.6% 29th Share of one-year-olds who received the inactivated polio vaccine 69.0% 2024 up 81.6% 174th Deaths in armed conflicts by country, annual growth rate -94.04 % change on previous year 2026 down 140.0% 21st Deaths in armed conflicts by region, annual growth rate -94.04 % change on previous year 2026 down 140.0% 21st Proportion of health care facilities with limited water services 39.79 2022 down 19.3% 9th HIV-positive TB patients on ART (antiretroviral therapy) 90.0% 2024 up 34.3% 94th Tuberculosis patients living with HIV receiving antiretroviral therapy 10,990 patients 2021 up 883.0% 8th Treatment success rate for patients treated for MDR-TB 96.0% 2022 up 50.0% 17th Treatment success rate: HIV-positive TB cases 88 2023 — 28th Prevalence of wasting, weight for height 7.2% 2023 down 11.1% 25th Estimated number of children (aged 0-17 years) who have lost one or 6.03 million 2024 up 33.4% 3rd Weight-for-height <-2 SD 7.2 2023 down 11.4% 26th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 60.0% 2025 — 143rd International Health Regulations core capacity scores, SPAR version 40 2025 — 112th Estimated number of malaria cases 35.18 million 2024 up 50.9% 2nd ← Previous Page 21 of 27 Next →